PRIMARY STUDY
Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder
Key Findings: Patients who used cannabis and presented with their first-episode of schizophrenia showed less cognitive functioning impairment when compared to the first-episode of schizophrenia in non-users.
Type of Study: Clinical Trial
Study Sample Size: 152
Study Result: Positive
Research Location(s): Czech Republic
Year of Pub: 2021
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Citation: Hájková M, et al. Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder. Cogn Neuropsychiatry. 2021; 26:257-272. doi: 10.1080/13546805.2021.1924649
Authors: Hájková M, Knížková K, Siroňová A, Keřková B, Jonáš J, Šustová P, Dorazilová A, Rodriguez M
